The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

News

ecancer sources relevant oncology news from key institutes, journals, governments, NGOs and charities, along with commissioned pieces from our dedicated news team.

ASCO 2022: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cance...

Bridge therapy may benefit some children with high-risk neuroblastoma

ASCO 2022: Dabrafenib plus trametinib significantly increases overall response rate in paediatric lo...

ASCO 2022: Autologous stem cell transplant showed improved progression-free survival in newly diagno...

ASCO 2022: Combination regimen improves overall survival in a type of newly diagnosed metastatic col...

ASCO 2022: Novel antibody-drug conjugate doubles progression-free survival in metastatic breast canc...

$ASCO 2022: High-dose ifosfamide demonstrated as a standard of care for recurrent and primary refractory ewing sarcoma$

ASCO 2022: High-dose ifosfamide demonstrated as a standard of care for recurrent and primary refract...

ASCO 2022: Lung cancer therapy could help patients live longer

ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide

ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein

Tweets by @ecancer

For the latest ecancer COVID-19 resources, click on this link

News

More from ecancer